OICR offers a number of funding opportunities for Ontario researchers throughout the year to help enable world-class cancer research across the province.

OICR Clinical Translation Clinical Acceleration Team Awards – Request for Applications (2026)

OICR is inviting applications for CT’s Clinical Acceleration Team Award (CATA) funding stream to support prospective clinical trials in which Molecular (Minimal) Residual Disease (MRD) assessment is a prespecified and integral component of the study design, and in which MRD results are explicitly linked to defined clinical decision points, management strategies or treatment adaptations. The intent of this funding opportunity is to support well-designed, decision-relevant studies that meaningfully advance MRD as a clinically actionable biomarker and contribute to the cumulative evidence required for future definitive evaluation and broader clinical adoption.

OICR Window-of-Opportunity (WOO) Trial – Call for Concepts (2026)

The Ontario Institute for Cancer Research (OICR) Window-of-Opportunity (WOO) Network is inviting concept submissions for WOO trials. In presurgical WOO trials, patients with resectable disease are treated for a brief “window” period between diagnosis and surgical resection with an experimental drug/treatment.